Virtus ETF Advisers’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-6,845
| Closed | -$379K | – | 629 |
|
2024
Q4 | $379K | Sell |
6,845
-3,093
| -31% | -$171K | 0.15% | 188 |
|
2024
Q3 | $327K | Hold |
9,938
| – | – | 0.15% | 225 |
|
2024
Q2 | $270K | Sell |
9,938
-9,990
| -50% | -$272K | 0.13% | 240 |
|
2024
Q1 | $724K | Buy |
19,928
+2,867
| +17% | +$104K | 0.38% | 120 |
|
2023
Q4 | $345K | Buy |
+17,061
| New | +$345K | 0.22% | 191 |
|
2021
Q4 | – | Sell |
-6,008
| Closed | -$129K | – | 396 |
|
2021
Q3 | $129K | Sell |
6,008
-311
| -5% | -$6.68K | 0.06% | 365 |
|
2021
Q2 | $183K | Buy |
+6,319
| New | +$183K | 0.08% | 384 |
|